 Depression serum melatonin patients primary breast cancer due peripheral metabolism Serum melatonin main metabolic product patients breast cancer BC fresh primary tumor secondary tumor patients untreated benign breast disease controls Circadian rhythms groups acrophases AM melatonin AM nocturnal melatonin concentrations group patients primary breast cancer controls circadian amplitudes melatonin contrast patients secondary BC nocturnal melatonin concentrations amplitudes similar controls results depression melatonin patients primary BC due enhanced degradation liver due reduced activity pineal gland